POSTE GEORGE (CIK 1180770) reported 11 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-02). Recent activity: Buy CAI (1,600 shares), Buy EXEL (8,367 shares), Sell EXEL (60,000 shares), Buy CAI (125,000 shares), Sell CAI (48,022 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-02 | Caris Life Sciences, Inc. (CAI) | Director | Buy | 1,600 | $24,992 |
| 2026-05-29 | EXELIXIS, INC. (EXEL) | Director | Buy | 8,367 | $0 |
| 2026-05-08 | EXELIXIS, INC. (EXEL) | Director | Sell | 60,000 | $2.7M |
| 2025-08-13 | Caris Life Sciences, Inc. (CAI) | Director | Buy | 125,000 | $305,000 |
| 2025-08-13 | Caris Life Sciences, Inc. (CAI) | Director | Sell | 48,022 | $1.4M |
| 2025-08-13 | Caris Life Sciences, Inc. (CAI) | Director | Sell | 91,495 | $2.7M |
| 2025-05-30 | EXELIXIS, INC. (EXEL) | Director | Buy | 9,812 | $0 |
| 2025-05-16 | EXELIXIS, INC. (EXEL) | Director | Buy | 20,634 | $407,934 |
| 2025-05-16 | EXELIXIS, INC. (EXEL) | Director | Sell | 20,634 | $948,958 |
| 2025-02-19 | EXELIXIS, INC. (EXEL) | Director | Buy | 15,874 | $325,417 |
| 2025-02-19 | EXELIXIS, INC. (EXEL) | Director | Sell | 15,874 | $551,463 |
Source: SEC Form 4 filings · as of 2026-06-02